Monro Bio

Monro Bio

门罗生物

Monro Bio

Biotech/Healthcare

Founded in 2016 and located at the Singularity Center in Changping District, Beijing, Beijing Monroe Biotechnology Co., Ltd. is a biotech company focused on developing next-generation cell therapy drugs, dedicated to the treatment of hematologic malignancies, solid tumors, and autoimmune diseases.

Latest round: Series A (2021)

Source: ChinaBulls — chinabulls.com

Last updated 2021-06-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.